black and white bed linen

Pharma Leadership Forum

“Accelerating Molecule-to-Market Through Integrated Innovation”

24th July 2026

Taj Skyline, Ahmedabad

About the Conclave

This Conclave unites senior Indian pharma and biotech leaders from CXOs and manufacturing heads to QA/QC directors and R&D pioneers to accelerate the molecule-to-market journey.

By blending visionary leadership keynotes with collaborative, data-driven panel discussions, the forum fosters cross-industry alignment to help top-tier strategic accounts modernize operations, solve complex regulatory challenges, and build resilient, future-ready pharmaions, the forum fosters cross-industry alignment to help top-tier strategic accounts modernize operations, solve complex regulatory challenges, and build resilient, future-ready pharma workflows.

Why Attend the Pharma Leadership Forum?

Learn from Peers:

Hear real-world perspectives from CXOs and senior leaders on biologics scale-up, digital QC, automation, and data-driven pharma operations.

Explore Integrated Workflows:

Experience focused sessions on digital QC, biologics manufacturing, and automation to see how connected technologies can improve speed, quality, and compliance.

End-to-End Insights:

Understand how integrated solutions can accelerate your molecule-to-market journey across R&D, QC, manufacturing, and commercialization.

Build Strategic Partnerships:

Engage directly with Danaher Life Sciences leadership and peers from top Indian pharma and biotech companies to explore long-term collaboration opportunities.

Who Should Attend?

✓ CXO / Site Leadership

✓ Manufacturing Heads

✓ Bioprocess Leaders

✓ QA/QC Directors

✓ R&D Leaders

✓ Analytical Development Teams

✓ Innovation and Digital Transformation Leaders

✓ Regulatory and Compliance Leaders

✓ Strategic Procurement Stakeholders

Mr. Kshitij Vijayvargiya

Director Regional Marketing, APAC Cytiva

Dr. Ravi Kumar Trivedi
Dr. Tulip Nuwal
Mr. Anand Varadarajan

Managing Director & Partner, Boston Consulting Group (BCG)

VP and head of business excellence and CGT, Intas Pharmaceuticals Ltd

Vice President, Zydus Life Sciences Limited

Meet Our Speakers

Mr. Joe Fox

President, Beckman Coulter Life Sciences, Danaher Corporation

Mr. Sanjay Murdeshwar

Regional President – India, Danaher Corporation

Dr. Ashish Tejam

Vice President, Life Sciences – India, Danaher Corporation

Agenda

07:00PM – 07:05PM Welcome Note
  • Mr. Ashish Tejam, Vice President, Danaher Lifesciences India

08:20PM – 08:50PM Panel Discussion: Building a Resilient Biopharma Ecosystem: Securing India's Path to Global Leadership
  • What lessons has the global biopharma industry learned from recent supply chain disruptions?

  • How can India strengthen its position as a strategic global partner for biologics and advanced therapeutics manufacturing?

  • What investments are required to build resilient upstream, downstream, and analytical capabilities?

  • How can organizations reduce dependency risks while maintaining competitiveness and innovation?

  • What role will digitalization, automation, AI, and connected manufacturing play in improving resilience?

  • How can industry, government, academia, and technology providers collaborate to accelerate ecosystem development?

  • What capabilities must India build today to lead the next generation of biologics, cell and gene therapies, and precision medicine?

07:05PM – 07:45PM Keynote Talks: From Capacity to Capability
  • Building India’s Global Pharma Leadership: Senior Industry Leader from Ahmedabad

  • Danaher’s Vision for India’s Life Sciences Future: Sanjay Murdeshwar, President India and High growth markets, Danaher

07:45PM – 08:15PM Panel Discssion: Unleashing the Tiger:
  • Can India Become the World's Innovation and CRDMO Hub?

  • What will it take for India to move from a cost-effective outsourcing destination to a global innovation partner?

  • How can India capture a larger share of the rapidly growing global CRDMO market?

  • What investments are required in talent, infrastructure, and advanced technologies?

  • How will biologics, cell and gene therapies, and next-generation modalities reshape India's opportunity?

  • What role will AI, digitalization, and automation play in accelerating India's competitiveness?

  • How can partnerships between pharma companies, CRDMOs, academia, and technology providers strengthen the ecosystem?

  • What policy and regulatory changes could further accelerate India's growth trajectory?

09:00PM – 10:00PM Networking Dinner
08:50PM – 09:00PM Thanksgiving and Closing note

Register Now

Contact Us

For Delegate Registration

Ms. Jyoti Chandani

jyoti@bluetech-media.com

+919324405931

© 2026. All rights reserved.